Research and Development

The Research and Development team at ReViral is dedicated to advancing innovative therapies for RSV infections. Led by experts in virology and preclinical development, the team focuses on discovering and optimizing drug candidates, conducting rigorous preclinical studies, and collaborating strategically to bring groundbreaking treatments from the lab to clinical trials. Their work is pivotal in addressing the urgent medical needs associated with RSV.